Skip to content

Respiratory Muscle Training for Athletes post COVID-19: A Pilot Study for a Randomised Controlled Trial to determine Efficacy in Improving Cardiorespiratory Fitness

Respiratory Muscle Training for Athletes post COVID-19: A Pilot Study for a Randomised Controlled Trial to determine Efficacy in Improving Cardiorespiratory Fitness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202305590076796
Enrollment
16
Registered
2023-05-02
Start date
2022-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Normal endurance training
Respiratory Muscle Training

Sponsors

Physiotherapy Department
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: COVID-19 convalescent endurance athletes including runners and cyclists. Male and female over the age of 18. Participants must reside in Johannesburg, South Africa Athletes who did cardiovascular exercise for three or more hours per week prior to contracting COVID-19 will be eligible. Athletes must comply with the published return to sport criteria i.e., 10 days rest after diagnosis and 7 symptom-free days, and the ability to carry out activities of daily living and walk 500m effortlessly (Elliott et al., 2020). Participants need to be able to run for 30 minutes at a comfortable pace. Those with co-morbidities or severe disease need to have consulted a sports physician prior to resumption of sport.

Exclusion criteria

Exclusion criteria: Athletes currently in quarantine or isolating due to a positive COVID-19 test result will be not be eligible to participate. Athletes experiencing a new onset of COVID-19 symptoms or a positive exposure within 10 days of commencing the study. Athletes who are already using RMT as part of their training programme post-COVID-19 will be excluded.

Design outcomes

Primary

MeasureTime frame
Compare the difference in MIP (mean and SD) from baseline to follow up between intervention and control groups. ;Compare the difference in VO2max (mean and SD) from baseline to follow up between intervention and control groups.

Secondary

MeasureTime frame
A between group comparison of RPE at baseline and follow up;COVID-19 symptoms, if any, they continue to experience.

Countries

South Africa

Contacts

Public ContactHelena van Aswegen

Personal Professor

helena.vanaswegen@wits.ac.za+27117173706

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026